S-1/A Filing

Silo Pharma, Inc. CIK: 1514183

Filing Information

Form Type	S-1/A
Accession Number	`0001213900-21-020667`
Period End Date	20201231
Filing Date	20210407
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	silo-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 49 Cash Flow Statement 70 Stockholders Equity 20

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.13M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$336.68K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$111.75K	USD	Point-in-time
Equity investments, at cost	`EquityMethodInvestmentAggregateCost`	$9.39K	USD	Point-in-time
Equity investments, at cost	`EquityMethodInvestmentAggregateCost`	$200.00	USD	Point-in-time
Notes receivable, net	`NotesAndLoansReceivableNetCurrent`	$200.00K	USD	Point-in-time
Notes receivable, net	`NotesAndLoansReceivableNetCurrent`	$23.50K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$16.33K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, par value (in Dollars per share)	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, par value (in Dollars per share)	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$241.09K	USD	Point-in-time
Inventory	`InventoryNet`	$33.48K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares designated	`TemporaryEquitySharesDesignated`	1.00M	shares	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares designated	`TemporaryEquitySharesDesignated`	1.00M	shares	Point-in-time
Inventory	`InventoryNet`	$156.37K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares issued	`TemporaryEquitySharesIssued`	-	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$493.85K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.43M	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares issued	`TemporaryEquitySharesIssued`	4,000.00	shares	Point-in-time
Total Assets	`Assets`	$1.43M	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	-	shares	Point-in-time
Total Assets	`Assets`	$493.85K	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	4,000.00	shares	Point-in-time
Redeemable Series A, Convertible Preferred stock,100 per share redemption and liquidation value (in Dollars per share)	`TemporaryEquityRedemptionPricePerShare`	$100.00	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock,100 per share redemption and liquidation value (in Dollars per share)	`TemporaryEquityRedemptionPricePerShare`	$100.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible note payable, net of discount	`ConvertibleNotesPayableCurrent`	$61.88K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Convertible note payable, net of discount	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$54.86K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$127.07K	USD	Point-in-time
Note payable - current portion	`NotesPayableCurrent`	-	USD	Point-in-time
Note payable - current portion	`NotesPayableCurrent`	$14.65K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$141.72K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$116.74K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Note payable - long-term portion	`LongTermNotesAndLoans`	$4.25K	USD	Point-in-time
Note payable - long-term portion	`LongTermNotesAndLoans`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$4.25K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	85.14M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	23.60M	shares	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$116.74K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	85.14M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	23.60M	shares	Point-in-time
Total Liabilities	`Liabilities`	$145.97K	USD	Point-in-time
Commitment and Contingencies (see Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitment and Contingencies (see Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, $0.0001 par value, 1,000,000 shares designated; None and 4,000 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively ($100 per share redemption value)	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Redeemable Series A, Convertible Preferred stock, $0.0001 par value, 1,000,000 shares designated; None and 4,000 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively ($100 per share redemption value)	`TemporaryEquityCarryingAmountAttributableToParent`	$400.00K	USD	Point-in-time
Common stock, $0.0001 par value, 500,000,000 shares authorized; 85,141,956 and 23,604,207 shares issued and outstanding at December 31, 2020 and 2019, respectively	`CommonStockValue`	$2.36K	USD	Point-in-time
Common stock, $0.0001 par value, 500,000,000 shares authorized; 85,141,956 and 23,604,207 shares issued and outstanding at December 31, 2020 and 2019, respectively	`CommonStockValue`	$8.51K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$7.03M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.63M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.76M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.66M	USD	Point-in-time
Total Stockholders Equity (Deficit)	`StockholdersEquity`	$1.28M	USD	Point-in-time
Total Stockholders Equity (Deficit)	`StockholdersEquity`	$-22.89K	USD	Point-in-time
Total Stockholders Equity (Deficit)	`StockholdersEquity`	$407.44K	USD	Point-in-time
Total Liabilities and Stockholders Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$1.43M	USD	Point-in-time
Total Liabilities and Stockholders Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$493.85K	USD	Point-in-time

Income Statement 49 line items

Line Item	Tag	Value	Unit	Period
SALES	`Revenues`	$40.57K	USD	Annual
SALES	`Revenues`	$40.92K	USD	Annual
COST OF SALES	`CostOfGoodsAndServicesSold`	$176.13K	USD	Annual
COST OF SALES	`CostOfGoodsAndServicesSold`	$27.39K	USD	Annual
GROSS PROFIT (LOSS)	`GrossProfit`	$13.18K	USD	Annual
GROSS PROFIT (LOSS)	`GrossProfit`	$-135.20K	USD	Annual
Compensation expense	`ShareBasedCompensation`	$755.99K	USD	Annual
Compensation expense	`ShareBasedCompensation`	$319.59K	USD	Annual
Professional fees	`ProfessionalFees`	$1.28M	USD	Annual
Professional fees	`ProfessionalFees`	$431.01K	USD	Annual
Product development	`DevelopmentCosts`	$62.55K	USD	Annual
Product development	`DevelopmentCosts`	$63.47K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$26.25K	USD	Annual
Insurance expense	`GeneralInsuranceExpense`	$30.19K	USD	Annual
Insurance expense	`GeneralInsuranceExpense`	$26.57K	USD	Annual
Bad debt (recovery), net	`BadDebtRecoveryExpense`	$-13.50K	USD	Annual
Bad debt (recovery), net	`BadDebtRecoveryExpense`	$165.38K	USD	Annual
Selling, general and administrative expenses	`GeneralAndAdministrativeExpense`	$120.84K	USD	Annual
Selling, general and administrative expenses	`GeneralAndAdministrativeExpense`	$87.01K	USD	Annual
Impairment Loss	`AssetImpairmentCharges`	-	USD	Annual
Impairment Loss	`AssetImpairmentCharges`	$29.44K	USD	Annual
Total operating expenses	`OperatingExpenses`	$2.44M	USD	Annual
Total operating expenses	`OperatingExpenses`	$943.59K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-930.40K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.57M	USD	Annual
Interest income	`InvestmentIncomeNet`	$11.54K	USD	Annual
Interest income	`InvestmentIncomeNet`	$12.20K	USD	Annual
Other income	`OtherIncome`	-	USD	Annual
Other income	`OtherIncome`	$3.00K	USD	Annual
Interest expense	`InterestExpenseDebt`	$269.04K	USD	Annual
Interest expense	`InterestExpenseDebt`	$62.74K	USD	Annual
Interest expense - related party	`InterestExpenseRelatedParty`	$189.00	USD	Annual
Interest expense - related party	`InterestExpenseRelatedParty`	$224.00	USD	Annual
Foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-2.95K	USD	Annual
Loss on debt extinguishment, net	`GainsLossesOnExtinguishmentOfDebt`	$-197.68K	USD	Annual
Net realized gain on equity investments (non-controlled/non-affiliated investments)	`NetRealizedGainOnEquityInvestmentsNoncontrollednonaffiliatedInvestments`	$138.03K	USD	Annual
Net unrealized loss on equity investments (non-controlled/non-affiliated investments)	`UnrealizedGainLossOnEquityInvestments`	$-9.19K	USD	Annual
Net unrealized loss on equity investments (non-controlled/non-affiliated investments)	`UnrealizedGainLossOnEquityInvestments`	$-170.19K	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-464.55K	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-82.89K	USD	Annual
NET LOSS	`NetIncomeLoss`	$-1.01M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-3.04M	USD	Annual
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	$69.00K	USD	Annual
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-3.11M	USD	Annual
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-1.01M	USD	Annual
Basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	Annual
Basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	Annual
Basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	23.47M	shares	Annual
Basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	65.95M	shares	Annual

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.01M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.04M	USD	Annual
Bad debt expense, net	`BadDebtExpense`	$165.38K	USD	Annual
Bad debt expense, net	`BadDebtExpense`	-	USD	Annual
Impairment loss	`AssetImpairmentCharges`	-	USD	Annual
Impairment loss	`AssetImpairmentCharges`	$29.44K	USD	Annual
Stock-based compensation	`AllocatedStockbasedCompensation`	$610.48K	USD	Annual
Stock-based compensation	`AllocatedStockbasedCompensation`	$177.96K	USD	Annual
Amortization of debt discount to interest expense	`OtherDepreciationAndAmortization`	$268.12K	USD	Annual
Amortization of debt discount to interest expense	`OtherDepreciationAndAmortization`	$61.88K	USD	Annual
Inventory write-down	`InventoryWriteDown`	$137.95K	USD	Annual
Inventory write-down	`InventoryWriteDown`	-	USD	Annual
Net realized gain on equity investments	`GainOnSaleOfInvestments`	$138.03K	USD	Annual
Net realized gain on equity investments	`GainOnSaleOfInvestments`	-	USD	Annual
Net unrealized loss on equity investments	`UnrealizedGainLossOnInvestments`	$-9.19K	USD	Annual
Net unrealized loss on equity investments	`UnrealizedGainLossOnInvestments`	$-170.19K	USD	Annual
Loss from debt extinguishment	`LossFromDebtExtinguishment`	$-197.68K	USD	Annual
Loss from debt extinguishment	`LossFromDebtExtinguishment`	-	USD	Annual
(Increase) in inventory	`IncreaseDecreaseInInventories`	$15.06K	USD	Annual
(Increase) in inventory	`IncreaseDecreaseInInventories`	$129.39K	USD	Annual
(Increase) decrease in prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$144.66K	USD	Annual
(Increase) decrease in prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-17.70K	USD	Annual
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$72.53K	USD	Annual
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$29.23K	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-1.16M	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-794.32K	USD	Annual
Proceeds from sale of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	Annual
Proceeds from sale of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	$191.94K	USD	Annual
Purchase of equity investment	`PurchaseOfEquityInvestment`	$-5.20K	USD	Annual
Purchase of equity investment	`PurchaseOfEquityInvestment`	-	USD	Annual
Collection on notes receivable	`ProceedsFromCollectionOfNotesReceivable`	-	USD	Annual
Collection on notes receivable	`ProceedsFromCollectionOfNotesReceivable`	$39.00K	USD	Annual
NET CASH PROVIDED BY INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$39.00K	USD	Annual
NET CASH PROVIDED BY INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$186.74K	USD	Annual
Proceeds from note payable - related party	`ProceedsFromRelatedPartyDebt`	$25.00K	USD	Annual
Proceeds from note payable - related party	`ProceedsFromRelatedPartyDebt`	$35.00K	USD	Annual
Proceeds from note payable	`ProceedsFromNotesPayable`	$18.90K	USD	Annual
Proceeds from note payable	`ProceedsFromNotesPayable`	-	USD	Annual
Repayment of note payable - related party	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-25.00K	USD	Annual
Repayment of note payable - related party	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-35.00K	USD	Annual
Net proceeds from convertible debt	`ProceedsFromConvertibleDebt`	-	USD	Annual
Net proceeds from convertible debt	`ProceedsFromConvertibleDebt`	$295.00K	USD	Annual
Repayment of insurance finance loan	`RepaymentOfInsuranceFinanceLoan`	-	USD	Annual
Repayment of insurance finance loan	`RepaymentOfInsuranceFinanceLoan`	$22.34K	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$2.13M	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$382.66K	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS:	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-224.93K	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS:	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$1.02M	USD	Annual
CASH AND CASH EQUIVALENTS - beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.13M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$336.68K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$111.75K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of year	`CashAndCashEquivalentsAtCarryingValue`	$1.13M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of year	`CashAndCashEquivalentsAtCarryingValue`	$336.68K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - end of year	`CashAndCashEquivalentsAtCarryingValue`	$111.75K	USD	Point-in-time
Interest	`InterestPaidNet`	-	USD	Annual
Interest	`InterestPaidNet`	$224.00	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Common stock issued for prepaid services	`CommonStockIssuedForPrepaidServices`	-	USD	Annual
Common stock issued for prepaid services	`CommonStockIssuedForPrepaidServices`	$686.89K	USD	Annual
Common stock issued for acquisition of intangible assets and prepaid expenses	`CommonStockIssuedForAcquisitionOfIntangibleAssetsAndPrepaidExpenses`	$300.00K	USD	Annual
Common stock issued for acquisition of intangible assets and prepaid expenses	`CommonStockIssuedForAcquisitionOfIntangibleAssetsAndPrepaidExpenses`	-	USD	Annual
Common Stock issued for Exchange of Notes	`CommonStockIssuedForExchangeOfNotesCash`	-	USD	Annual
Common Stock issued for Exchange of Notes	`CommonStockIssuedForExchangeOfNotesCash`	$528.00K	USD	Annual
Common stock issued for due diligence fee and related increase in debt discount	`CommonStockIssuedForDueDiligeCommonStockIssuedForDueDiligenceFeeAndRelatedIncreaseInDebtDiscountnceFeeAndRelatedIncreaseInDebtDiscount`	$42.00K	USD	Annual
Common stock issued for due diligence fee and related increase in debt discount	`CommonStockIssuedForDueDiligeCommonStockIssuedForDueDiligenceFeeAndRelatedIncreaseInDebtDiscountnceFeeAndRelatedIncreaseInDebtDiscount`	-	USD	Annual
Warrants issued in connection with convertible debt and related increase in debt discount	`WarrantsIssuedInConnectionWithConvertibleDebtAndRelatedIncreaseInDebtDiscount`	-	USD	Annual
Warrants issued in connection with convertible debt and related increase in debt discount	`WarrantsIssuedInConnectionWithConvertibleDebtAndRelatedIncreaseInDebtDiscount`	$253.00K	USD	Annual
Common Stock issued for conversion of Redeemable Series A Preferred stock	`CommonStockIssuedForConversionOfRedeemableSerieAPreferredStock`	-	USD	Annual
Common Stock issued for conversion of Redeemable Series A Preferred stock	`CommonStockIssuedForConversionOfRedeemableSerieAPreferredStock`	$400.00K	USD	Annual

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$1.28M	USD	Point-in-time
Balance	`StockholdersEquity`	$-22.89K	USD	Point-in-time
Balance	`StockholdersEquity`	$407.44K	USD	Point-in-time
Series B preferred stock issued for cash, net of costs	`StockIssuedDuringPeriodValueOther`	$110.00K	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$35.00K	USD	Annual
Common stock issued for due diligence fee	`CommonStockIssuedForDueDiligenceFee`	$42.00K	USD	Annual
Accretion of stock options for services	`StockIssueDuringPeriodAccretionOfStockOptionsForServices`	$142.96K	USD	Annual
Warrants issued in connection with convertible debt	`DebtConversionConvertedInstrumentAmount1`	$253.00K	USD	Annual
Common Stock issued for cash, net of offering cost	`StockIssuedDuringPeriodValueNewIssues`	$2.12M	USD	Annual
Common Stock issued for future services	`StockIssuedForFutureServices`	$686.89K	USD	Annual
Common Stock issued in connection with employment agreement	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$610.48K	USD	Annual
Common Stock issued in connection with employment agreement (in Shares)	`StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan`	4.12M	shares	Point-in-time
Common Stock issued for Exchange of Notes	`CommonStockIssuedForExchangeOfNotes`	$528.00K	USD	Annual
Common Stock issued for conversion of Redeemable Series A Preferred stock	`CommonStockIssuedForConversionOfRedeemableSeriesPreferredStock`	$400.00K	USD	Annual
Deemed dividend on Preferred Stock Exchange	`DeemedDividendOnPreferredStockExchange`	-	USD	Annual
Net loss	`ProfitLoss`	$-1.01M	USD	Annual
Net loss	`ProfitLoss`	$-3.04M	USD	Annual
Balance	`StockholdersEquity`	$1.28M	USD	Point-in-time
Balance	`StockholdersEquity`	$-22.89K	USD	Point-in-time
Balance	`StockholdersEquity`	$407.44K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.